Efficacy and adverse effects of oral propranolol in infantile hemangioma: a meta-analysis of comparative studies

Background A number of clinical trials evaluated the efficacy and adverse effects of oral propranolol in the treatment of infantile hemangioma (IH), but the treatment has not yet been standardized. This meta-analysis aims to reevaluate the efficacy and adverse effects of oral propranolol in comparat...

Full description

Saved in:
Bibliographic Details
Published in:World journal of pediatrics : WJP 2019-12, Vol.15 (6), p.546-558
Main Authors: Yang, Hao, Hu, Dong-Lai, Shu, Qiang, Guo, Xiao-Dong
Format: Article
Language:English
Subjects:
Critical Care Medicine
Imaging
Intensive
Maternal and Child Health
Medicine
Medicine & Public Health
Meta-Analysis
Pediatric Surgery
Pediatrics
Radiology
Surgery
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background A number of clinical trials evaluated the efficacy and adverse effects of oral propranolol in the treatment of infantile hemangioma (IH), but the treatment has not yet been standardized. This meta-analysis aims to reevaluate the efficacy and adverse effects of oral propranolol in comparative studies and to provide a reliable basis for clinical administration in the therapy for IH. Methods Data were obtained from PubMed, Embase, Cochrane Library, Web of Science, China National Knowledge Infrastructure and Wanfang database, from inception to December 1st, 2018. The pooled risk ratios (RR) with 95% confidence intervals (95% CI) were calculated and used to evaluate the effect size. The meta-analysis was performed using the random-effects model due to heterogeneity between the studies. The Cochrane Collaboration 6 aspects of bias, methodological index for non-randomized studies and the Newcastle–Ottawa Scale were used to assess the risk for bias. Sensitivity analysis, publication bias and subgroup analysis were performed. Results Eighteen unique studies involving 2701 unique children were included in the analysis. The response rate was reported in 18 trials, which compared oral propranolol with other treatments. The heterogeneity was statistically significant ( P  
ISSN:1708-8569
1867-0687
DOI:10.1007/s12519-019-00285-9